Accession Number | HMDB00655 |
Common_Name | Cholestane-3,7,12,25-tetrol |
Description | Cholestane-3,7,12,25-tetrol is an intermediate in the bile acid biosynthetic pathways accumulating (together with other 25-hydroxylated bile alcohols intermediates and cholestanol) in Cerebrotendinous xanthomatosis (CTX, a rare recessively inherited lipid storage disease characterized by a markedly reduced production of chenodeoxycholic acid) (PMID 11181760) |
Chemical_IUPAC_Name | (3R,5R,7R,8S,9R,10S,12R,13R,14R)-17-[(2R)-6-hydroxy-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol |
Chemical Formula | C27H48O4 |
Sample Concentration | Not Available |
Mass Value | Not Available |
Mass Unit | Not Available |
Manufacturer | Not Available |
Analyzer | Not Available |
Delivery | Not Available |
Ionization | Not Available |
Predicted 1H NMR Spectrum | Download |
Predicted 1H NMR Peaklist | Download |
Predicted 13C NMR Spectrum | Download |
Predicted 13C NMR Peaklist | Download |
Sample Concentration | Not Available |
Mass Value | Not Available |
Mass Unit | Not Available |
Manufacturer | Not Available |
Frequency | Not Available |
1H NMR Spectrum | Not Available |
Sample Concentration | Not Available |
Mass Value | Not Available |
Mass Unit | Not Available |
Manufacturer | Not Available |
Frequency | Not Available |
13C NMR Spectrum | Not Available |
Low Energy Voltage | Not Available |
Low Energy Spectrum | Not Available |
Low Energy Peaklist | Not Available |
Medium Energy Spectrum | Not Available |
Hight Energy Spectrum | Not Available |